Hello and Welcome to Patientsville.com, Your Source for all IMURAN information. We are dedicated to provide You with IMURAN safety information. Learn about IMURAN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
IMURAN Safety Reports
Total IMURAN reports: 9.IMURAN FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 5.
Take IMURAN Side Effects Survey or Share Your IMURAN Story. Read More Here.
Physician from UNITED STATES reported IMURAN problem on Jan 29, 2007. Male patient, 33 years of age, was diagnosed with crohn's disease and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant, metastases to lung. IMURAN dosage: 50 MG; QD; PO. During the same period patient was treated with PENTASA, IMODIUM A. Patient was hospitalized. Patient recovered.
IMURAN problem was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Female patient, weighting 31.31 lb, was diagnosed with b precursor type acute leukaemia and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: blood electrolytes abnormal, hypotension, influenza serology positive, renal failure, sepsis, tachycardia. IMURAN dosage: 50 MG DAILY PO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported IMURAN problem on May 29, 2007. Male patient was diagnosed with polychondritis and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, asthenia, chills, disorientation, dizziness, fatigue, headache, myalgia, pyrexia. IMURAN dosage: unknown. Patient was hospitalized. Patient recovered.
IMURAN problem was reported by a Pharmacist from UNITED STATES on Aug 16, 2006. Female patient was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, sepsis. IMURAN dosage: unknown. Patient died.
Health Professional from UNITED STATES reported IMURAN problem on Sept 07, 2006. Female patient, weighting 110.0 lb, was diagnosed with lung transplant and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: adverse event, laboratory test abnormal, therapeutic product contamination. IMURAN dosage: 100 MG QD PO. Patient recovered.
IMURAN problem was reported by a Pharmacist from UNITED STATES on Nov 14, 2006. Female patient, 81 years of age, weighting 220.5 lb, was diagnosed with autoimmune hepatitis and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: pancreatic pseudocyst, pancreatitis. IMURAN dosage: 50MG DAILY PO. During the same period patient was treated with HYDROCHLOROTHIAZIDE, PREDNISONE. Patient recovered.
Physician from UNITED STATES reported IMURAN problem on July 06, 2007. Male patient, 38 years of age, was diagnosed with crohn's disease and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: mediastinal mass, non-hodgkin's lymphoma stage ii. IMURAN dosage: 150 MG;QD;PO. During the same period patient was treated with ACETAMINOPHEN, CYANOCOBALAMIN, BUDESONIDE, ACETAMINOPHEN W. Patient recovered.
IMURAN problem was reported by a Physician from UNITED STATES on Aug 07, 2006. Male patient, 62 years of age, was diagnosed with colitis and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: pancreatitis. IMURAN dosage: unknown. During the same period patient was treated with URSODIOL, RABEPRAZOLE, CLOPIDOGREL, ASPIRIN, EZETIMIBE, MESALAMINE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported IMURAN problem on Aug 28, 2007. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: asthenia, condition aggravated, multiple sclerosis, pyrexia. IMURAN dosage: 50MG TID PO 3 WKS PTA. During the same period patient was treated with PREVACID, BACLOFEN, ACTONEL, KLONOPIN, COPAXONE. Patient was hospitalized. Patient recovered.